AgelessRx, a pioneer in longevity and telehealth solutions, announced the introduction of oral sublingual drops for GLP-1 receptor agonists Semaglutide and Tirzepatide. By offering non-injectable ...
Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
Online pharmacies will need a proper consultation, not just a patient's questionnaire, to prescribe jabs such as Mounjaro ...
Previously, the drugs were able to be prescribed through an email chat, from questionnaires or by people sending in photos of ...
Pharmacists must verify a person’s body mass index (BMI) via a video consultation, in person, or through accessing GP or ...
The pharmacy regulator is working with other bodies to jointly tackle inappropriate advertising and promotions of the drugs ...
New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & ...
Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback